AstraZeneca Pharma India Limited
NSE:ASTRAZEN.NS
7306.8 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 12,955.262 | 10,029.708 | 8,056 | 8,085.6 | 8,317.7 | 7,282.4 | 5,710 | 5,395.701 | 5,264.598 | 4,690.488 | 4,737.482 | 3,888.249 | 5,312.797 | 5,940.25 | 3,855.212 | 3,397.685 | 2,973.137 | 2,644.104 | 2,224.212 |
| Cost of Revenue
| 8,509.498 | 4,576.933 | 3,574.6 | 3,305.4 | 3,343.7 | 2,696.3 | 2,235.5 | 2,018.513 | 2,128.076 | 2,029.515 | 1,801.551 | 1,722.883 | 1,859.559 | 1,859.736 | 1,251.156 | 1,037.807 | 984.275 | 0 | 0 |
| Gross Profit
| 4,445.764 | 5,452.775 | 4,481.4 | 4,780.2 | 4,974 | 4,586.1 | 3,474.5 | 3,377.187 | 3,136.522 | 2,660.972 | 2,935.93 | 2,165.365 | 3,453.238 | 4,080.514 | 2,604.056 | 2,359.878 | 1,988.861 | 2,644.104 | 2,224.212 |
| Gross Profit Ratio
| 0.343 | 0.544 | 0.556 | 0.591 | 0.598 | 0.63 | 0.608 | 0.626 | 0.596 | 0.567 | 0.62 | 0.557 | 0.65 | 0.687 | 0.675 | 0.695 | 0.669 | 1 | 1 |
| Reseach & Development Expenses
| 728.6 | 591.6 | 391.9 | 287.6 | 227 | 0 | 0 | 0 | 0 | 0 | 102.813 | 163.712 | 141.158 | 20.94 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,890.602 | 299.3 | 247.5 | 271.1 | 273.5 | 235.7 | 124.2 | 164.949 | 160.979 | 176.868 | 172.176 | 175.654 | 1,031.184 | 1,077.467 | 786.009 | 609.424 | 477.61 | 0 | 0 |
| Selling & Marketing Expenses
| 860.072 | 597.417 | 507.2 | 452.1 | 557.6 | 798 | 728.1 | 544.107 | 728.158 | 666.192 | 454.969 | 416.603 | 256.35 | 329.178 | 134.285 | 79.969 | 97.292 | 0 | 0 |
| SG&A
| 2,750.674 | 597.417 | 754.7 | 723.2 | 831.1 | 1,033.7 | 852.3 | 709.056 | 889.137 | 843.059 | 627.145 | 592.256 | 1,287.534 | 1,406.645 | 920.294 | 689.393 | 574.902 | 0 | 0 |
| Other Expenses
| 348.004 | 4,343.867 | 3,030.2 | 2,894.4 | 3,117.3 | 2 | 4.8 | 3.958 | 9.45 | 6.716 | 10.389 | 6.596 | 1,784.641 | 1,698.849 | 787.414 | 28.986 | 554.692 | 1,894.593 | 1,576.451 |
| Operating Expenses
| 2,750.674 | 4,941.284 | 3,784.9 | 3,617.6 | 3,948.4 | 4,022.3 | 3,133.2 | 3,100.561 | 3,143.39 | 2,891.963 | 3,165.458 | 2,960.451 | 3,213.333 | 3,126.434 | 1,707.708 | 1,302.352 | 1,129.594 | 1,894.593 | 1,576.451 |
| Operating Income
| 1,695.09 | 945.089 | 814.6 | 1,263.9 | 1,148.2 | 563.8 | 341.3 | 196.7 | -6.868 | -262.607 | -225.971 | -806.717 | 239.904 | 954.08 | 896.347 | 1,057.526 | 859.268 | 749.511 | 647.761 |
| Operating Income Ratio
| 0.131 | 0.094 | 0.101 | 0.156 | 0.138 | 0.077 | 0.06 | 0.036 | -0.001 | -0.056 | -0.048 | -0.207 | 0.045 | 0.161 | 0.233 | 0.311 | 0.289 | 0.283 | 0.291 |
| Total Other Income Expenses Net
| 500.26 | 395.959 | 15.8 | 7 | -8.5 | 162.9 | 96.7 | 135.348 | 64.504 | 54.21 | 218.427 | 104.017 | 52.644 | 55.384 | -12.426 | 86.234 | 94.221 | 0 | 0 |
| Income Before Tax
| 2,195.35 | 1,341.048 | 830.4 | 1,270.9 | 1,139.7 | 726.7 | 438 | 332.048 | 57.636 | -208.397 | -7.544 | -702.7 | 292.548 | 1,009.463 | 883.922 | 1,143.76 | 953.489 | 749.511 | 647.761 |
| Income Before Tax Ratio
| 0.169 | 0.134 | 0.103 | 0.157 | 0.137 | 0.1 | 0.077 | 0.062 | 0.011 | -0.044 | -0.002 | -0.181 | 0.055 | 0.17 | 0.229 | 0.337 | 0.321 | 0.283 | 0.291 |
| Income Tax Expense
| 580.264 | 348.121 | 214.4 | 337.9 | 417.6 | 182.2 | 178.9 | 87.626 | 5.047 | 62.458 | 5.089 | 192.623 | 94.897 | 368.166 | 307.749 | 405.408 | 338.903 | 262.149 | 217.18 |
| Net Income
| 1,615.1 | 992.9 | 616 | 933 | 722.1 | 544.5 | 259.1 | 244.423 | 52.59 | -208.397 | -5.089 | -895.323 | 197.651 | 641.298 | 576.172 | 738.352 | 614.586 | 487.362 | 430.581 |
| Net Income Ratio
| 0.125 | 0.099 | 0.076 | 0.115 | 0.087 | 0.075 | 0.045 | 0.045 | 0.01 | -0.044 | -0.001 | -0.23 | 0.037 | 0.108 | 0.149 | 0.217 | 0.207 | 0.184 | 0.194 |
| EPS
| 64.6 | 39.72 | 24.64 | 37.32 | 28.88 | 21.78 | 10.36 | 8 | 2.1 | -8.34 | -0.2 | -35.81 | 7.91 | 25.65 | 23.05 | 29.53 | 24.58 | 19.49 | 17.22 |
| EPS Diluted
| 64.6 | 39.72 | 24.64 | 37.32 | 28.88 | 21.78 | 10.36 | 8 | 2.1 | -8.34 | -0.2 | -35.81 | 7.91 | 25.65 | 23.05 | 29.53 | 24.58 | 19.49 | 17.22 |
| EBITDA
| 1,844.495 | 1,107.689 | 984.1 | 1,461.4 | 1,334 | 712.4 | 506.9 | 439.135 | 166.979 | -47.334 | -291.002 | -729.951 | 308.865 | 1,044.448 | 957.114 | 1,260.861 | 911.76 | 806.82 | 699.707 |
| EBITDA Ratio
| 0.142 | 0.11 | 0.122 | 0.181 | 0.16 | 0.098 | 0.089 | 0.081 | 0.032 | -0.01 | -0.061 | -0.188 | 0.058 | 0.176 | 0.248 | 0.371 | 0.307 | 0.305 | 0.315 |